Mannatech Valuation

Q: What is the Fair Price of MTEX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

MTEX ($8.05) is trading above our estimate of [[fair value]] ($6.9)

Is MTEX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MTEX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MTEX ($8.05) is trading above our estimate of fair value ($6.9)

Significantly Below Fair Value: MTEX is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MTEX?

Key metric: As MTEX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MTEX. This is calculated by dividing MTEX's market cap by their current revenue.
What is MTEX's PS Ratio?
PS Ratio	0.1x
Sales	US$121.55m
Market Cap	US$15.17m

MTEX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.09x
Enterprise Value/EBITDA	8.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does MTEX's PS Ratio compare to its peers?

The above table shows the PS ratio for MTEX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.7x
DQWS DSwiss	6x	n/a	US$15.1m
INBP Integrated BioPharma	0.2x	n/a	US$10.2m
GRAM Gold Flora	0.09x	21.4%	US$11.4m
CVSI CV Sciences	0.5x	n/a	US$7.5m
MTEX Mannatech	0.1x	n/a	US$15.2m

Price-To-Sales vs Peers: MTEX is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.7x).

Price to Sales Ratio vs Industry

How does MTEX's PS Ratio compare vs other companies in the US Personal Products Industry?

28 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.0x	4.7%
MTEX Mannatech	0.1x	n/a	US$15.17m
HLF Herbalife	0.2x	1.8%	US$778.11m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$377.31m

28 Companies		Estimated Growth	Market Cap
Industry Avg.	1.0x	25.5%
MTEX Mannatech	0.1x	n/a	US$15.17m

No more companies

Price-To-Sales vs Industry: MTEX is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Personal Products industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is MTEX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MTEX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate MTEX's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ascend Wellness Holdings

US$100.8m

Engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

AAWH

US$0.47

-17.0%

-59.9%

Beauty Health

US$200.5m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.62

-12.7%

-27.4%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.7b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.45

n/a